Clinical Trial Update: Bevacizumab for Primary Pterygium Treatment [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated bevacizumab for primary pterygium. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pterygium

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Pterygium | Phase 1 | Status: COMPLETED